Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2.
The platelet aggregation-inducing factor Aggrus, also known as podoplanin, is frequently upregulated in several types of tumors and enhances hematogenous metastasis by interacting with and activating the platelet receptor CLEC-2. Thus, Aggrus-CLEC-2 binding could be a therapeutic molecular mechanism...
Enregistré dans:
Auteurs principaux: | Satoshi Takagi, Shigeo Sato, Tomoko Oh-hara, Miho Takami, Sumie Koike, Yuji Mishima, Kiyohiko Hatake, Naoya Fujita |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/371badaf6d0b449ca1ff7fa393a4d7f9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The podoplanin-CLEC-2 axis inhibits inflammation in sepsis
par: Julie Rayes, et autres
Publié: (2017) -
Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation
par: Kenichi Miyata, et autres
Publié: (2017) -
Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A/TLR2
par: Pei-Shan Sung, et autres
Publié: (2019) -
Clec4A4 is a regulatory receptor for dendritic cells that impairs inflammation and T-cell immunity
par: Tomofumi Uto, et autres
Publié: (2016) -
The platelet receptor CLEC-2 blocks neutrophil mediated hepatic recovery in acetaminophen induced acute liver failure
par: Abhishek Chauhan, et autres
Publié: (2020)